SMAD2 and neoplasm: In conclusion, this study reveals that tumor-derived, exosome-mediated miR-125b possesses anti-metastatic properties by targeting SMAD2, as well as by inhibiting MMPs and TGF-β1/SMAD signaling pathway in EMT via intercellular communication (Figure 5E).